Viatris Inc: Drug Recall

Recall #D-0063-2023 · 10/21/2022

Class II: Risk

Recall Details

Recall Number
D-0063-2023
Classification
Class II
Product Type
Drug
Recalling Firm
Viatris Inc
Status
Terminated
Date Initiated
10/21/2022
Location
Canonsburg, PA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,794 bottles

Reason for Recall

Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.

Product Description

Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05

Distribution Pattern

Nationwide in the USA

Other Recalls by Viatris Inc

View all recalls by Viatris Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.